References
- Sondel P M, Kohier P C, Hank J A, et al. Clinical and immunological effects of recombinant Interleukin 2 given by repetitive weekly cycles to patients with cancer. Cancer Res 1988; 48: 2561–2567
- Sofman J A, Kohier P A, Hank J, et al. Repetitive weekly cycles of human Interleukin-2: responses of renal carcinoma with acceptable toxicity. J Natl Cancer Inst 1988; 80: 60–63
- Thompson J A, Lee D J, Cox W W, et al. Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a Phase I trial. Cancer Res 1987; 47: 4202–4207